Atrial natriuretic peptide(s) (ANP) (Atriopeptin) are peptide hormones that regulate vasodilation. The ANP fragment Atriopeptin III (ANP 127-150) is used to study the regulation of Na+/H+ exchange mediated in erythrocytes by cGMP/guanylate-cyclase activity.
The American journal of physiology, 271(5 Pt 1), C1556-C1564 (1996-11-01)
Guanylate cyclase activity in human erythrocytes is investigated by evaluating the intracellular guanosine 3',5'-cyclic monophosphate (cGMP) content in the presence of various agents that exert specific effects on soluble or particulate guanylate cyclase. The increase in the intraerythrocyte cGMP content
Clinical and experimental pharmacology & physiology, 24(2), 131-138 (1997-02-01)
1. In mammalian plasma, many different inhibitors of Na+/K(+)-ATPase are present, but it is not clear whether their net effect on NA+/K(+)-ATPase activity changes during the regulation of electrolyte and fluid balance. We studied Na+/K(+)-ATPase inhibition by plasma extracts in
European journal of biochemistry, 221(1), 195-199 (1994-04-01)
Human atrial natriuretic peptide (ANP) fragments ANP-(127-150) or ANP-III and ANP-(127-149) or ANP-II activate Na+/H+ exchange in human erythrocytes at concentrations as low as 1 pM. Both ANP-(127-147) or ANP-I and ANP-(129-150) or des-Ser5, Ser6-ANP-III have no effect on erythrocyte
Questions
Reviews
★★★★★ No rating value
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.